
Prostate Cancer Highlights From ASCO 2025
Key findings on prostate cancer treatment from the 2025 ASCO meeting are reported by Dr Oliver Sartor from Tulane Medical School in New Orleans. Dr Sartor begins by highlighting the phase 3 AMPLITUDE trial, which evaluated niraparib (NIRA) combined with …